COPD Palliative Care and End-of-Life Management in COPD 1 — Questions and Answers
Question 1: Which validated tool is most commonly used to assess dyspnea severity in COPD patients receiving palliative care?
- Borg Scale
- Modified Medical Research Council (mMRC) Dyspnea Scale (Correct answer)
- St. George's Respiratory Questionnaire
- BODE Index
Correct answer: Modified Medical Research Council (mMRC) Dyspnea Scale
The mMRC Dyspnea Scale is the most widely used validated tool for grading dyspnea severity and guiding palliative interventions in COPD.
Question 2: According to GOLD guidelines, at which stage of COPD should palliative care discussions ideally be initiated?
- Only at GOLD Stage IV (Very Severe)
- At GOLD Stage III or IV when disease is significantly impacting quality of life (Correct answer)
- Only when the patient is hospitalized for exacerbations
- After the patient requests hospice enrollment
Correct answer: At GOLD Stage III or IV when disease is significantly impacting quality of life
GOLD recommends integrating palliative care discussions early in severe disease (Stage III/IV) rather than waiting until the terminal phase.
Question 3: Which pharmacological agent is considered first-line for relieving refractory dyspnea in end-stage COPD patients?
- Lorazepam
- Morphine (low-dose oral or parenteral) (Correct answer)
- Haloperidol
- Prednisone
Correct answer: Morphine (low-dose oral or parenteral)
Low-dose systemic opioids, particularly morphine, have the strongest evidence base for palliating refractory dyspnea in end-stage COPD.
Question 4: An advance directive that specifically documents a patient's wishes regarding mechanical ventilation and resuscitation in COPD is best described as a:
- POLST (Physician Orders for Life-Sustaining Treatment) (Correct answer)
- Durable power of attorney for finances
- Healthcare proxy designation
- Do-not-resuscitate order only
Correct answer: POLST (Physician Orders for Life-Sustaining Treatment)
A POLST form translates patient wishes into actionable medical orders, including decisions about ventilation and CPR, making it actionable across care settings.
Question 5: What is the primary goal of early integration of palliative care alongside standard COPD treatment?
- To reduce healthcare costs by limiting interventions
- To improve quality of life and align care with patient goals throughout the disease course (Correct answer)
- To discontinue all bronchodilator therapy
- To enroll patients in hospice as soon as possible
Correct answer: To improve quality of life and align care with patient goals throughout the disease course
The primary goal of concurrent palliative care is to optimize quality of life, manage symptoms, and ensure care reflects patient values at all stages of disease.
Question 6: Which factor is MOST predictive of poor prognosis in COPD patients and should trigger palliative care referral?
- Mild hypoxemia during exercise only
- FEV1 <30% predicted combined with frequent exacerbations and functional decline (Correct answer)
- Use of short-acting beta-agonists more than twice weekly
- A smoking history of 20 pack-years
Correct answer: FEV1 <30% predicted combined with frequent exacerbations and functional decline
Very low FEV1 combined with frequent exacerbations and declining function is a strong prognostic indicator that warrants proactive palliative care integration.
Question 7: A COPD educator is supporting a patient who fears 'air hunger' at death. Which intervention is MOST appropriate to address this concern?
- Reassure the patient that air hunger never occurs if oxygen is used
- Educate about symptom management options including opioids, anxiolytics, and a comfort-focused plan (Correct answer)
- Advise the patient to avoid thinking about end-of-life scenarios
- Recommend immediate hospice enrollment regardless of current status
Correct answer: Educate about symptom management options including opioids, anxiolytics, and a comfort-focused plan
Educating the patient about available symptom control options, including opioids and anxiolytics, empowers them and reduces fear of suffering at end of life.
Which validated tool is most commonly used to assess dyspnea severity in COPD patients receiving palliative care?